Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.
about
Conjugate vaccines for preventing meningococcal C meningitis and septicaemiaPolysaccharide vaccines for preventing serogroup A meningococcal meningitisConjugate vaccines for preventing meningococcal C meningitis and septicaemiaProspects for vaccine prevention of meningococcal infectionMucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialVaccines against meningococcal disease: current and future technologies.Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in miceA phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine.Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.Vaccination in the neonatal period and early infancy.Active immunization in the United States: developments over the past decade.Differences in surface expression of NspA among Neisseria meningitidis group B strains.Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccineMucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescentsSerological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses.Surface plasmon resonance analysis of antipolysaccharide antibody specificity: responses to meningococcal group C conjugate vaccines and bacteriaProtein carriers of conjugate vaccines: characteristics, development, and clinical trials.Rethinking recommendations for use of pneumococcal vaccines in adults.Persistence of group C anticapsular antibodies two to three years after immunization with an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccineMeningococcal serogroup C conjugate vaccine.Development and characterization of anti-idiotype based peptide and DNA vaccines which mimic the capsular polysaccharide of Neisseria meningitidis serogroup C.Priming for immunologic memory in adults by meningococcal group C conjugate vaccination.Safety and efficacy of meningococcal group C conjugate vaccines.Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.Meningococcal group C conjugate vaccines.Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine.Critical analysis of old and new vaccines against N. meningitidis serogroup C, considering the meningococcal disease epidemiology in Brazil.Managing meningococcal disease case clusters: art or science?Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.Neisseria meningitidis serogroup A vaccines: an overview.Serologic correlates of protection for evaluating the response to meningococcal vaccines.Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.Meningococcal disease serogroup C.Control and lot release of meningococcal group C conjugate vaccines.Recent developments in Neisseria meningitidis group A conjugate vaccines.
P2860
Q24235722-1ED23EAB-CEC5-4AA9-803B-574E504F5884Q24244832-43297D81-2D29-40EB-AD4E-53C62908A5FAQ24244951-88BB2B02-CA4C-4BB8-9AE3-62CD23090452Q24537338-6B70B5A3-D0F6-40E7-A108-17BD8B581E7FQ28187952-D74F6BC3-5538-4E55-ACAF-E8A4544841C0Q28650557-2A6B8D62-C08A-4A1D-BE93-340EA4781971Q30771493-05A9D218-8B5D-42A8-B75D-CF0DFD5C888CQ30802758-04B610A8-3F62-47D1-B157-76D5AF8D88C3Q33334377-28862EED-6F2B-4040-819E-BEB94EA076CFQ33754255-3445E85C-0F27-48D9-86B7-50C0969F49C6Q33767903-898C4198-D817-433A-8941-860CEB014046Q33891058-3F3D7F76-FA49-4E50-8C37-89FB66EF0449Q33975799-F4D464E6-B29A-4C83-AB99-C254127DDE7EQ34002334-3CEEAE8B-855D-4514-B80A-1517ECAF845DQ34003052-6797CD11-B88C-4595-BEC9-8A0C70696750Q34004276-74F48C61-BE3C-4B3B-A5F9-43DBF5E4B6EBQ34006352-C8E8A890-68BE-43C7-AF0F-56681B26805CQ34006865-6A2FACD4-AD40-4A86-8D99-787C8128D928Q34126015-57D2CBAD-82B4-4AA2-A029-DB702869D2FDQ34145007-64A4A8A0-FA75-4E74-8A13-79374AE72E84Q34170021-E3E85E15-E82B-495A-8CE7-D49A1AE076E1Q34326459-0BE5ACF6-7354-441B-9697-5FA7DEFE37B6Q34480575-4787A846-5786-4060-9162-086DD645269DQ34482078-BF3307EE-C80F-4445-AD5C-867E7CCBE0BEQ34552305-9F66F956-FC31-4D62-93C7-A5FE793376EEQ34720293-C05FFF54-03C1-489D-99DC-21BD6B30C5CDQ35194432-B137BF96-AD23-44D2-9359-EACDDC9F0A03Q35229074-C08BA01E-794B-4298-A009-9EDB39CCE949Q35269816-97BB3A2E-9D57-457E-9FDB-E2FC3B14F032Q35542416-AF46055F-380E-4968-B7FC-E4FB5D23BA2AQ35546445-F74542E5-DE93-4A57-9CA8-8D74F7EB8A53Q35554452-F67C9F1F-6893-4FAC-86B5-B70DE5A87304Q35559127-B9755FA4-20E8-4F25-A150-F0A86FF765D0Q35588006-9709225E-E1E9-4FCA-8E07-33D36EFAD345Q35623344-21E190AA-C330-4CC3-B6DE-5A99D6F64CB2Q35648260-A3D7A499-9AFE-4334-AB53-A1351211580AQ35801994-4CEBC790-4016-4EED-A971-73B5447C56DDQ35832179-6CABF48B-AE40-4F50-AD3E-5A88428F9F93Q35918490-A326243A-7833-4A21-AE4A-10A21D91F74BQ36065978-68270DCE-3062-446E-B3F1-948BBA0F16BD
P2860
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Induction of immunologic memor ...... ide-protein conjugate vaccine.
@en
Induction of immunologic memor ...... ide-protein conjugate vaccine.
@nl
type
label
Induction of immunologic memor ...... ide-protein conjugate vaccine.
@en
Induction of immunologic memor ...... ide-protein conjugate vaccine.
@nl
prefLabel
Induction of immunologic memor ...... ide-protein conjugate vaccine.
@en
Induction of immunologic memor ...... ide-protein conjugate vaccine.
@nl
P2093
P356
P1476
Induction of immunologic memor ...... ide-protein conjugate vaccine.
@en
P2093
Carlone GM
Forrest BD
Granoff DM
LiButti DE
P304
P356
10.1093/INFDIS/175.1.200
P407
P577
1997-01-01T00:00:00Z